WTW announces new global agreement to deploy Radar. LONDON, Sept. 21, 2026 (GLOBE NEWSWIRE) - WTW (NASDAQ: WTW) today announced a global agreement with Zurich Insurance Company Limited (Zurich) to deploy Radar, WTW's market-leading end-to-end rating and analytics software, to help improve pricing sophistication and risk selection across the Swiss insurer's target Retail markets worldwide. This new global agreement, which follows a rigorous selection process, builds on and significantly expands the two companies' existing agreement, under which WTW successfully integrated WTW's Radar technology across its primary Retail lines within a number of country-level markets. Soledad Mune, Group Head of Retail Transformation, Zurich, said: "Improved pricing sophistication and risk selection are critical to long-term profitability in retail. WTW brings proven knowledge and reliability, and Radar offers a market-leading pricing platform, global adoption and ease of scaling through a centralized tech infrastructure. We look forward to further capitalizing on WTW's expertise." Georgy Matov, Managing Director and Zurich Global Relationship Leader, Insurance Consulting and Technology, WTW, said: "We are delighted Zurich has chosen Radar as its global pricing solution, which expands our successful collaboration. We will apply our deep industry expertise and insurance technology solutions to help Zurich enhance its pricing and risk management capabilities through advanced functionality across monitoring, analytics, decision-making and deployment. "Radar continues to develop at an unprecedented pace, with the latest release including ground-breaking insurance-honed AI portfolio management capabilities." Built specifically for the insurance industry, Radar provides a suite of advanced capabilities, helping both personal and commercial lines insurers to unlock smarter, data-driven decision-making at scale. Key benefits include real-time insights for more accurate risk assessments, cutting-edge AI techniques, enhanced pricing accuracy, and unprecedented speed and agility for pricing, portfolio management, claims and underwriting. About Radar Radar is a leading insurance technology platform that unifies pricing, underwriting, and claims into a single end-to-end solution. Built by insurance specialists and backed by more than 30 years of industry innovation, Radar leverages proprietary analytics and advanced generative AI capabilities to help personal and commercial lines insurers make faster, smarter, and more confident decisions across the insurance lifecycle. Trusted by more than 500 insurers worldwide, Radar enables organizations to improve operational efficiency, accelerate growth, and deliver measurable business outcomes at scale. Radar is part of WTW's Insurance Consulting and Technology business, which helps insurers navigate complexity and drive transformation through a unique combination of deep insurance expertise, strategic advisory services, and market-leading technology. About Insurance Consulting and Technology WTW's Insurance Consulting and Technology business is a global leader in P&C, Life, and Health insurance software and advisory services. With over 1,700 colleagues in 35 markets, we combine deep insurance expertise with leading-edge technology to help insurers navigate complexity and unlock value across pricing, underwriting, reserving, financial and capital modeling, claims, portfolio management, and regulatory reporting. We're redefining insurance through innovation and technology. By harnessing Generative and Agentic AI, we're creating next-generation processes that reduce friction, enhance decision-making, and unlock faster, smarter outcomes for our clients. These capabilities accelerate innovation and enable us to deliver with unmatched precision and scale. More than 1,000 insurers across six continents - including many of the world's leading insurance groups - trust our unique combination of advisory insight and advanced software to power their businesses and drive sustainable growth. About WTW At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce and maximize performance. Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success - and provide perspective that moves you.

Life Sciences Week 2026 welcomes Willis (WTW) as sponsor and host of dedicated clinical-trials risk event. * Partnership brings specialist insurance and risk-management expertise to Life Sciences Week's national community. * Willis will exhibit and contribute to a panel at the Launch Day Conference in Birmingham on 21 September. * The session on 22 September will examine clinical-trial risk, delays, liabilities and practical ways to strengthen medical programmes. Life Sciences Week has announced Willis (WTW), as a strategic partner and sponsor for its 2026 programme, bringing specialist insurance, risk-management and advisory expertise to the UK's life sciences community. Willis supports organisations across life sciences, biotechnology and healthcare to understand and manage complex risks. Through the partnership, its specialists will connect with the researchers, founders, business leaders and investors shaping the sector's future. Life Sciences Week event: From lab to market: Managing clinical trials risk with confidence As part of Life Sciences Week, Willis (WTW) will host a discussion on Tuesday 22 September, from 09:00 to 10:00, exploring the risks affecting clinical trials today. The panel will bring together a representative from a clinical trial sponsor, an insurer and specialists from Willis (WTW) to discuss common risks and how they can be managed. The discussion will look at why trials run late or over budget, common insurance and liability issues, and what organisations can do to avoid problems. The session will end with a live Q&A with the panel. Willis will also have an exhibitor presence throughout the Life Sciences Week Launch Day Conference at Millennium Point, Birmingham, on Monday 21 September, and will contribute to a panel discussion. The wider partnership will include thought-leadership content developed for the Life Sciences Week audience. Life Sciences Week 2026 runs from 21-25 September, with panels, roundtables, site visits, showcases, networking and sector-led events across Birmingham, the West Midlands and locations nationwide. Amy Deakin, Managing Director of Life Sciences Week, said: "Life sciences businesses have to manage risk from the earliest stages of research through to taking a product to market. Whether a founder is preparing for due diligence or a sponsor is running a clinical trial, getting good advice early can help prevent delays, unexpected costs and avoidable problems. "Willis (WTW) understands the insurance and risk issues facing the sector. At the Launch Day Conference and its clinical-trials session, the team will share straightforward advice that attendees can use in their own organisations." Sara Fardon, Regional Director, WTW Midlands, said: "Clinical trials are complex, and problems can quickly lead to delays, additional costs or legal issues. Organisations need a clear understanding of where problems are most likely to arise and what they can do to reduce the risk. "We're looking forward to meeting people from across the sector at Life Sciences Week, sharing our experience and starting conversations that continue beyond the event." To find out more about Life Sciences Week 2026, visit: LSW 2026 Website.